These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 17191110)

  • 1. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells.
    Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
    Clin Exp Med; 2006 Dec; 6(4):177-90. PubMed ID: 17191110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer.
    Sánchez-Suárez P; Ostrosky-Wegman P; Gallegos-Hernández F; Peñarroja-Flores R; Toledo-García J; Bravo JL; Del Castillo ER; Benítez-Bribiesca L
    Mutat Res; 2008 Apr; 640(1-2):8-15. PubMed ID: 18207203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of DNA damage in radiotherapy-treated cancer patients using the alkaline comet assay.
    Gamulin M; Garaj-Vrhovac V; Kopjar N
    Coll Antropol; 2007 Sep; 31(3):837-45. PubMed ID: 18041397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factor.
    Uriol E; Sierra M; Comendador MA; Fra J; Martínez-Camblor P; Lacave AJ; Sierra LM
    Mutagenesis; 2013 Jan; 28(1):39-48. PubMed ID: 22987025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer.
    Jaremko M; Justenhoven C; Schroth W; Abraham BK; Fritz P; Vollmert C; Illig T; Simon W; Schwab M; Brauch H
    Pharmacogenet Genomics; 2007 Jul; 17(7):529-38. PubMed ID: 17558308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation sensitivity of leukocytes from healthy individuals and breast cancer patients as measured by the alkaline and neutral comet assay.
    Shahidi M; Mozdarani H; Bryant PE
    Cancer Lett; 2007 Nov; 257(2):263-73. PubMed ID: 17881118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic outcomes of adjuvant chemotherapy in non-target cells of breast cancer patients.
    Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
    Hum Exp Toxicol; 2007 May; 26(5):391-9. PubMed ID: 17623763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of DNA sensitivity in peripheral blood leukocytes after occupational exposure to microwave radiation: the alkaline comet assay and chromatid breakage assay.
    Garaj-Vrhovac V; Orescanin V
    Cell Biol Toxicol; 2009 Feb; 25(1):33-43. PubMed ID: 18214694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.
    Hurria A; Brogan K; Panageas KS; Pearce C; Norton L; Jakubowski A; Zauderer M; Howard J; Hudis C
    Breast Cancer Res Treat; 2005 Jul; 92(2):151-6. PubMed ID: 15986124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of DNA damage in white blood cells of healthy human volunteers using the alkaline comet assay and the chromosome aberration test.
    Kopjar N; Zeljezić D; Garaj-Vrhovac V
    Acta Biochim Pol; 2006; 53(2):321-36. PubMed ID: 16582984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity of environmental agents assessed by the alkaline comet assay.
    Møller P
    Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy.
    Suhail N; Bilal N; Khan HY; Hasan S; Sharma S; Khan F; Mansoor T; Banu N
    J Clin Pharm Ther; 2012 Feb; 37(1):22-6. PubMed ID: 21204889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer.
    Schrohl AS; Meijer-van Gelder ME; Holten-Andersen MN; Christensen IJ; Look MP; Mouridsen HT; Brünner N; Foekens JA
    Clin Cancer Res; 2006 Dec; 12(23):7054-8. PubMed ID: 17114213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
    de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
    Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals.
    Sigurdson AJ; Hauptmann M; Alexander BH; Doody MM; Thomas CB; Struewing JP; Jones IM
    Mutat Res; 2005 Oct; 586(2):173-88. PubMed ID: 16099702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of toxicities induced by chemotherapy in breast cancer patients.
    Mehreen L; Khanam A
    Biomed Pharmacother; 2005 Oct; 59(9):524-7. PubMed ID: 16154313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-induced DNA damage and repair in peripheral blood mononuclear cells from Nijmegen breakage syndrome patients and carriers assessed by the Comet assay.
    Bürger S; Schindler D; Fehn M; Mühl B; Mahrhofer H; Flentje M; Hoehn H; Seemanová E; Djuzenova CS
    Environ Mol Mutagen; 2006 May; 47(4):260-70. PubMed ID: 16470524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary evaluation of DNA damage related with the smoking habit measured by the comet assay in whole blood cells.
    Ellahueñe MF; Pérez-Alzola LP; Farfán-Urzua M; González-Hormazabal P; Garay M; Olmedo MI; Last JA
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1223-9. PubMed ID: 15247134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
    Ejlertsen B; Mouridsen HT; Jensen MB
    Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.